HMRC EIS APPROVED INVESTMENT – UP TO 30% TAX RELIEF

Please enter your details to request more information

Invest in new revolutionary AI technology, reducing healthcare costs and transforming the care of cancer and diabetes.

With 17.2x target returns including EIS Tax Relief

Investment Highlights

• Supported by an Innovate UK, Government grant.
• 43.2% Forecast Growth (CAGR) of the global AI healthcare market by 2032 (representing a $490 Bn market).
• £55,190,250 forecast revenue by year 5.
• In collaboration with the government-backed Medicine’s Discover Catapult – Accelerating the development of high growth technology in medicine.
• Chief AI have built a world class AI infrastructure using proprietary platforms.

Dr Farid Khan PhD

CSO

University of Cambridge. World renowned drug discovery scientist

CIO of Medicine’s Discovery Cataput

Leading external AI algorithm supply

Dr John Overington

CEO

Led multi-million pound AI & machine learning implementations across the EMEA region

Waqar Ali Shah

Next-generation medical care

• Predictive Oncology – predicting disease outcomes including lung and breast cancer.
• Diabetes Care - The next level of monitorisation, management and treatment optimisation.
• Discovery & Biotech – Predicting drug target interactions.
• Access to the most extensive biological datasets.
• Unmatched medical research capabilities.
• Enables machine-to-machine AI Connectivity.

To be able to deal with your enquiry effectively we will need to contact you via telephone and/or email. By enquiring you consent to being contacted and you consent to your data being stored in accordance with European GDPR regulations. Privacy Policy

Disclaimer: Any person accessing this website or page and considering potential investment opportunities featured here, should make their own commercial assessment of an investment opportunity after seeking the advice of an appropriately authorised or regulated financial advisor. This website or page should not be construed as advice or a personal recommendation to any prospective investor. Investments of this nature carry risks to your capital and can go up or down. Past performance is not indicative of future results. Suitable appropriately qualified investors, sophisticated and high net worth investors only.